Your bridge to New Zealand and Oceania healthcare.
Translyx partners with global diagnostic and clinical-AI innovators — bringing world-class technology to New Zealand and Oceania with local expertise, governance, and clinical adoption. Aiforia is our authorised digital pathology AI partner, and the network is growing.
A trusted local partner for global innovators.
Bringing diagnostic and AI technology into a new region takes more than distribution. Translyx provides the clinical, regulatory, and operational bridge to adopt it well.
Market access
Direct reach into hospitals, laboratories, pathology groups, and research teams across New Zealand and Oceania.
Clinical & regulatory navigation
Local expertise to position technology appropriately — careful compliance and no implied regulatory endorsement.
Governed adoption
Reviewer-gated, privacy-first deployment so clinical AI is adopted with confidence and human oversight.
Implementation & support
Hands-on evaluation, onboarding, training, and ongoing local support across clinical and research settings.
Distribution & logistics
Operational, supply, and logistics support for diagnostic products entering the region.
A trusted local entity
An accountable New Zealand company representing your brand to local healthcare and research organisations.
The companies behind Translyx solutions.
Authorised Partner Solution
Aiforia Technologies Plc
AI-assisted digital pathology for clinical, preclinical, and research workflows. Represented by Translyx in New Zealand as an authorised business partner.
Explore AiforiaSoftware Partner
Privexa Limited
Builds the protected AI software layer — AI Wrapper, Cloud Shield, Scribe, Trace, and ClinicalTriage — clinically positioned through Translyx.
View productsAiforia is an authorised partner solution represented by Translyx in New Zealand — not owned or developed by Translyx. Privexa-built products are developed by Privexa Limited and clinically positioned through Translyx.
New partners are joining — announcing soon.
Translyx is actively bringing new diagnostic and AI partners to New Zealand and Oceania across these areas.
Diagnostics partner
Sepsis & AMR diagnostics
Partner in discussion to bring this capability to New Zealand and Oceania.
Diagnostics partner
Molecular & oncology
Partner in discussion to bring this capability to New Zealand and Oceania.
Diagnostics partner
Point-of-care testing
Partner in discussion to bring this capability to New Zealand and Oceania.
Become a partner
Bring your innovation to New Zealand and Oceania.
If you build diagnostic technology, digital pathology AI, or protected clinical software, Translyx can be your accountable local partner — handling clinical positioning, governance, adoption, and implementation across the region.
Let's bring world-class clinical technology to the region.
Whether you're a global innovator seeking local adoption or a healthcare organisation evaluating partner solutions — Translyx is the bridge.